Centiva Capital, LP
Q3 2020 13F-HR Holdings
Net value change ($000)
-135,364
(-8.2%)
New positions
306
Sold out positions
235
Turnover %
64.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LQD | 68,290 | NEW |
| WFC | 14,333 | 6204.8% |
| KBE | 9,198 | 614.8% |
| TIFFANY & CO | 8,919 | 961.1% |
| VARIAN MEDICAL SYSTEMS INC | 7,740 | NEW |
| Cyxtera Technologies, Inc. | 7,597 | NEW |
| Executive Network Partnering Corp | 7,575 | NEW |
| IMMUNOMEDICS INC | 6,889 | 1250.3% |
| IBB | 6,683 | 65.3% |
| GOOGL | 6,511 | 231.1% |
Top Reduces (Value $000, Stocks/ETFs)
| JNJ | -11,463 | -100.0% |
| CHX | -10,990 | -100.0% |
| ILMN | -10,398 | -93.1% |
| AAPL | -9,150 | -68.3% |
| USMV | -8,568 | -100.0% |
| Change Healthcare Inc. | -5,894 | -100.0% |
| PYPL | -5,588 | -50.9% |
| Advanced Disposal Services, Inc. | -4,986 | -95.1% |
| MAR | -4,539 | -100.0% |
| ABBV | -4,536 | -76.4% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
898,368
(59.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|